Filing Flows

Filing Flows › Health Care › Privia Health Group (PRVA)

Privia Health Group (PRVA) earnings and revenue breakdown

Latest: Q3 2026 · 10-Q filed Nov 5, 2026 · Privia Health Group (PRVA) Q3 2026 earnings results →

Q3 2026 Revenue up 13% year over year to $657M · 2¢ of every $1 of revenue kept as net profit · operating margin 3.1%

Privia Health Group made $657M in Q3 2026 (+13% Y/Y): FFS-patient care $433M, Capitated revenue $99.5M, Shared savings $68.8M. Operating margin 3.1%, net earnings $13.5M. See where every dollar goes — costs, profit and cash — as a Sankey from the 10-Q filed Nov 5, 2026.

Revenue$657M
Year over year+13%
Operating margin3.1%
Net earnings$13.5M
Operating cash flow$28.9M

Drawing the Sankey…

Open the interactive Sankey → click any line for what the company wrote about it, compare Y/Y and Q/Q, export as PNG or PDF

What changed this quarter

Revenue was $657.0M in Q3 2026, up 13% year over year and up 4% from the previous quarter. FFS-patient care was the largest line at 66% of revenue. FFS-patient care added $80.5M year over year (up 23%), 105% of the total change. Shared savings declined 14%.

Operating profit was $20.5M, a 3.1% margin (up 0.6 points year over year). Of the extra revenue versus Q3 2025, 8% reached operating profit, above the 2% margin then. Total costs grew 12% against revenue growth of 13%. The fastest-growing cost line was Sales & marketing (+43%). Net earnings were $13.5M, up 97% year over year. The effective tax rate was 34.5%.

Operating cash flow was $28.9M (down 44% year over year), 198% of net income including minority interests. Non-cash charges added back $3.5M of depreciation and amortization and $14.0M of share-based compensation. Working capital and other items used $3.2M.

Quarterly history

Privia Health Group revenue by quarterPrivia Health Group revenue by quarter$480MQ1 2025$521MQ2 2025$580MQ3 2025$541MQ4 2025$604MQ1 2026$633MQ2 2026$657MQ3 2026
Privia Health Group net earnings by quarterPrivia Health Group net earnings by quarter$4.2MQ1 2025$2.7MQ2 2025$6.9MQ3 2025$9.2MQ4 2025$3.1MQ1 2026$9.0MQ2 2026$13.5MQ3 2026
QuarterFormFiledRevenueY/YOp. marginNet earningsOp. cash flow
Q3 202610-QNov 5, 2026$657M+13%3.1%$13.5M$28.9M
Q2 202610-QAug 6, 2026$633M+21%1.9%$9.0M$1.1M
Q1 202610-QMay 7, 2026$604M+26%1.2%$3.1M−$49.5M
Q4 202510-KFeb 27, 2026$541M+17%2.1%$9.2M$128M
Q3 202510-QNov 6, 2025$580M+32%2.5%$6.9M$52.0M
Q2 202510-QAug 7, 2025$521M+23%0.6%$2.7M$8.0M
Q1 202510-QMay 8, 2025$480M+16%1.1%$4.2M−$24.1M

Charts

Privia Health Group: revenue growth, year over year and quarter over quarterPrivia Health Group: revenue growth, year over year and quarter over quarterY/YQ/Q+16%Q1 2025+23%+9%Q2 2025+32%+11%Q3 2025+17%-7%Q4 2025+26%+12%Q1 2026+21%+5%Q2 2026+13%+4%Q3 2026
Latest (Q3 2026): Y/Y +13%, Q/Q +4%.
Privia Health Group: where the cash came from (+) and went (−), TTM to Q3 2026Privia Health Group: where the cash came from (+) and went (−), TTM to Q3 2026Operating cash flow$108MAcquisitions−$103MShares issued$11.0MPartners−$8.9MCash drawn (+) / kept (−)−$4.9MOther financing−$1.3MOther investing−$1.1M
From the cash-flow statement as filed (SEC XBRL). Cash is fungible: the bars do not say which dollar paid for what.
Privia Health Group: profit against cash, quarter by quarterPrivia Health Group: profit against cash, quarter by quarterNet incomeOperating cash flow$5.4M$74.8MQ4 2024$6.0M−$24.1MQ1 2025$3.3M$8.0MQ2 2025$9.8M$52.0MQ3 2025$10.6M$128MQ4 2025$3.7M−$49.5MQ1 2026$9.7M$1.1MQ2 2026$14.6M$28.9MQ3 2026
Latest (Q3 2026): Net income $14.6M, Operating cash flow $28.9M.
Privia Health Group: diluted shares by fiscal yearPrivia Health Group: diluted shares by fiscal year96MFY2020103MFY2021111MFY2022125MFY2023126MFY2024129MFY2025
+34.3% since FY2020: more shares outstanding (issuance, stock pay).
Privia Health Group in its industry: growth against margin (14 companies, SIC 8000)Privia Health Group in its industry: growth against margin (14 companies, SIC 8000)revenue growth, year over year →↑ operating marginmedian +13%median 3%LFSTPIIIPNTGINNVUSPHWGSOMDADCGOTalkspace, Inc.VSEELDDDATPCNPLYPRVA (+13%, 3%)
Services-Health Services; dot size is quarterly revenue; dashed lines are the industry's medians.

Interactive views

The same charts as the app — open one to draw it.

💵Where each $1 goesinteractive

Loading the interactive chart…

🌏Named in Asian annual reportsinteractive

Loading the interactive chart…

🔄Rotation against the market and its industry (RRG)interactive

Loading the interactive chart…

🔍Earnings qualityinteractive

Loading the interactive chart…

⚖️Fair value by methodinteractive

Loading the interactive chart…

🔭Outlook & guidanceinteractive

Loading the interactive chart…

📈Investments: gains and what it boughtinteractive

Loading the interactive chart…

🏭Its industry’s money flow (input-output)interactive

Loading the interactive chart…

About Privia Health Group

Privia Health Group, Inc. (“Privia Health”, “we”, “our”, or the “Company”) is a technology-driven, national physician-enablement company that collaborates with physician practices, health plans, and health systems to achieve the quadruple aim of better outcomes, lower costs, improved patient experience, and happier and more engaged providers. We seek to accomplish the quadruple aim by entering markets and organizing existing physicians and non-physician clinicians into a unique practice model that combines the advantages of a partnership in a large regional medical group (each, a “Medical Group”) with significant provider autonomy for the physicians (collectively, “Privia Physicians”) and non-physician clinicians (collectively “Privia Clinicians” and, together with the Privia Physicians, the “Privia Providers”) in our Medical Groups.

In its own words, from its 10-K, filed Feb 27, 2026.

Privia Health Group against its Services-Health Services peers

The largest companies of the same SEC industry, each at its latest quarter. Revenue growth: +13% against the peers' median +13%. Operating margin: 3.1% against the peers' median 5.5%.

CompanyQuarterRevenueY/YOp. margin
PRVA Privia Health GroupQ3 2026$657M+13%3.1%
LFST LifeStance Health GroupQ3 2026$456M+25%7.3%
PIII P3 Health PartnersQ2 2026$386M+9%10.7%
PNTG Pennant GroupQ3 2026$302M+32%5.5%
INNV InnovAge HoldingQ1 FY27$265M+12%7.6%
USPH U S Physical TherapyQ3 2026$223M+13%11.3%
WGS GeneDx HoldingsQ2 2026$114M+11%-15.3%
OMDA Omada HealthQ3 2026$91.3M+34%5.3%
DCGO DocGoQ2 2026$73.4M-9%-24.4%

Source: Privia Health Group 10-Q on SEC EDGAR · CIK 1759655 · Services-Health Services

Guidance and outlook

Privia Health Group: what its forward-looking statements are about (10-Q filed 2026-11-05)Privia Health Group: what its forward-looking statements are about (10-Q filed 2026-11-05)Other10Demand9Costs2Margins2The economy1Products1
25 statements; tone +0.48 (−1 all cautious, +1 all confident); 6 hedged.
Privia Health Group: outlook statements against the filing beforePrivia Health Group: outlook statements against the filing beforeConfident14Cautious2

13F: who owns PRVA and who is buying

Largest holders of PRVA (13F)Largest holders of PRVA (13F)BlackRock$551MFMR LLC$331MDurable Capital Partners LP$299MVanguard Group$284MVanguard Portfolio Management LLC$169MRubicon Founders LLC$154MVanguard Capital Management LLC$133MState Street$126MGeode Capital Management, LLC$80.6MRiverbridge Partners LLC$77.2M
Funds' net buying of PRVA by quarter (13F)Funds' net buying of PRVA by quarter (13F)$56.6M2024-09$23.2M2024-12$24.2M2025-03−$65.2M2025-06$51.5M2025-09$21.5M2025-12$67.5M2026-03−$53.8M2026-06
Value of shares 13F filers added minus the value they sold, each quarter (quarters with most filings in).

More on PRVA

History

Every quarter: Q3 2026 results · Q2 2026 results · Q1 2026 results · Q4 2025 results · Q3 2025 results · Q2 2025 results · Q1 2025 results

Compare PRVA with

中文版:Privia Health Group(PRVA)财报

Español · Français